• EE470 Cost-Effectiveness of Gabapentin, Pregabalin, and Duloxetine in the Treatment of Painful Diabetic Neuropathy: A Real-World Data-Based Net Benefit Regression Analysis

    Jul 1, 2025, 00:00

  • RWD24 Optimizing EHR Data Completeness: A Conceptual Framework for Bringing Real-World Data into Clinical Research through Relevant Completeness

    Jul 1, 2025, 00:00

  • PCR239 Improving Patient Engagement Outcomes: A Pilot Study to Investigate the Role of Empathy in Scientific Writing

    Jul 1, 2025, 00:00

  • HPR14 A Different Approach to the Overall Survival Conversation: A Bayesian Analysis of Overall Survival Benefits Among Oncology Accelerated Approvals

    Jul 1, 2025, 00:00

  • PCR124 Factors Influencing the Quality of Life of Stroke Survivors: Results of an Online Survey in the US

    Jul 1, 2025, 00:00

  • MSR51 Maximizing the Impact of In-Trial Interviews Through AI Assisted Analysis

    Jul 1, 2025, 00:00

  • RWD71 Health Care Resource Utilization (HCRU), and Direct Medical Costs Among Patients With Locally Advanced or Metastatic HER2 Negative Gastric Cancer (GC) in the United States

    Jul 1, 2025, 00:00

  • PCR214 Correlation and Predictors of EORTC QLQ-C30 GHS-QoL and EQ-5D VAS in Patients With Advanced NSCLC

    Jul 1, 2025, 00:00

  • EPH147 Distribution, Inequalities and Associated Factors of Unmet Medical Needs Among Older Adults: Evidence From The National Health Service Survey

    Jul 1, 2025, 00:00

  • EE408 Healthcare Resource Utilization And Costs Following Disease Progression With First-Line Systemic Therapy In Patients With Advanced Endometrial Cancer in the US

    Jul 1, 2025, 00:00

  • P33 Introduction of Distress Thermometer (DT) Screening in the US Community Oncology Setting: A Retrospective Study of Electronic Health Records (EHR) Integration

    Jul 1, 2025, 00:00

  • SA14 Economic Systematic Literature of Nirmatrelvir+Ritonavir for the Treatment of Patients With Mild to Moderate COVID-19

    Jul 1, 2025, 00:00

  • The Role of Mental Health in Healthcare Choices: A Discrete Choice Experiment Examining Preferences for Primary Care

    Jul 1, 2025, 00:00

  • RWD171 Baseline BMI and HbA1c Trends in US Diabetic Patients Initiating GLP-1 Therapy: A Retrospective Cohort Study

    Jul 1, 2025, 00:00

  • PCR36 Enhancing Methods to Explore Meaningful Change in Patient Interviews: A Case Study in Spinocerebellar Ataxia (SCA)

    Jul 1, 2025, 00:00

  • RWD90 Analysis and Management of Computable Operational Definition (CODef) Concept Variation Based on a Large Real-World Studies Library

    Jul 1, 2025, 00:00

  • MSR7 Transforming Regulatory Intelligence With AI Driven Methodologies in HEOR

    Jul 1, 2025, 00:00

  • PCR177 Patient-Reported Outcomes in Indirect Treatment Comparisons: A Targeted Literature Review

    Jul 1, 2025, 00:00

  • P42 Transportability of Treatment Effect Measures for Binary Outcomes in Population-Adjusted Indirect Comparisons

    Jul 1, 2025, 00:00

  • HTA68 Strategic Implications of EU HTAR (JCA and JSC) for Global Biopharma and Biotechs: Navigating Evolving Paradigms in Market Access

    Jul 1, 2025, 00:00

  • PCR15 Psychosocial Distress and Quality of Life Among Minority Men Diagnosed with Prostate Cancer: A Systematic Review

    Jul 1, 2025, 00:00

  • EPH12 Estimating Epidemiological Estimates of Rare Diseases in Reimbursement Submissions to Canada's Drug Agency: A Comparison of Approaches in the Absence of Local Real-World Data

    Jul 1, 2025, 00:00

  • HSD57 Highly Effective Use of a Medical Affairs Team with Medical Science Liaison-delivered Education: The SMART-MSL Study

    Jul 1, 2025, 00:00

  • HPR75 Is the IRA Drug Price Negotiation an Evidence-Based Practice? A Critical Analysis of the Evidence Reviewed by CMS for IRA Drug Price Negotiations and Implications for Future Submissions

    Jul 1, 2025, 00:00

  • HTA36 Horizon Scanning for Paroxysmal Nocturnal Hemoglobinuria in Brazil: Insights on Past Trends and Future Prospects

    Jul 1, 2025, 00:00

  • HSD106 Assessing Infection Prevention Staffing and Resource Allocation Across Single and Multi-Facility Hospitals: A Comparative Analysis

    Jul 1, 2025, 00:00

  • PCR108 Assessing the Impact of Sociodemographic Factors on Patient Perceptions of Chronic Heart Failure Management

    Jul 1, 2025, 00:00

  • RWD35 Real-World Impact Of Recurrence On Overall Survival (OS) In Patients With Unresectable Locally Advanced (LA) Esophageal/Gastroesophageal Junction Cancer (EC/GEJC) Treated With Definitive Chemoradiotherapy (dCRT) In US Community Oncolo ...

    Jul 1, 2025, 00:00

  • MSR117 Estimation of Utilities for Patients with Metastatic Breast Cancer Using Vignette in Japan

    Jul 1, 2025, 00:00

  • PCR30 Perfect Health Reporting on EQ-5D-5L: The Role of Personal, Family and Social Network Illness Experiences

    Jul 1, 2025, 00:00

  • EE347 Updated 1-Year Fracture Incidence and Costs of Fragility Fractures in US Post-Fracture Patients Based on Commercial Claims Databases

    Jul 1, 2025, 00:00

  • PCR91 Patient Reported Outcomes in BRUIN CLL-321: A Phase 3 Trial of Pirtobrutinib Versus Idelalisib Plus Rituximab or Bendamustine Plus Rituximab in BTK Inhibitor Pretreated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

    Jul 1, 2025, 00:00

  • MSR100 Can Gen-AI Assist in Translating Health Economic Data Across Formats? A Proof-of-Concept for an HEOR Translator Tool

    Jul 1, 2025, 00:00

  • EPH47 Characteristics Correlated with Limited Physical Functioning in US Adults with Arthritis: A Cross-Sectional Database Analysis of the Medical Expenditure Panel Survey

    Jul 1, 2025, 00:00

  • MSR62 Keeping With the Times: Emerging Methods for More Precise Survival Estimates to Inform Cost-Effectiveness Analysis

    Jul 1, 2025, 00:00

  • EE513 Assessing the Economic Impact of Biosimilars in the U.S.: A cost analysis of Infliximab, Trastuzumab, and Rituximab

    Jul 1, 2025, 00:00

  • HSD92 Use of Novel Therapies for Multiple Myeloma in the United States: Important Differences in Patient Characteristics, Access to Care, and Real-World Treatment Challenges

    Jul 1, 2025, 00:00

  • PCR136 Consumer and Healthcare Provided Preferences for Adult Combination COVID-19 and Influenza Vaccines: Results from a Discrete Choice Study in France, Italy and Germany

    Jul 1, 2025, 00:00

  • MT6 Improving Cancer Recurrence Detection using ctDNA Measures in Colorectal, Breast, and Non-small Cell Lung Cancers

    Jul 1, 2025, 00:00

  • EPH33 Tinnitus Risk After XBB.1.5 COVID-19 Vaccination: A Self-Controlled Case Series Study

    Jul 1, 2025, 00:00

  • EPH110 Trends in Vaccinations by Medicare Part D Beneficiaries

    Jul 1, 2025, 00:00

  • HTA88 What's Cost Got To Do With It? A Review of Key Issues Related to Costs in Health Technology Assessments in Non-Small-Cell Lung Cancer

    Jul 1, 2025, 00:00

  • EE515 Measuring the Spillover Effect of Cancer on Family Members' Health: A US-Based Empirical Analysis

    Jul 1, 2025, 00:00

  • PCR167 Hypertension Medication Use and Primary Medication Non-Adherence Among Postpartum Women

    Jul 1, 2025, 00:00

  • MSR118 Cognitive Impairment Detection through Recurrent Neural Networks and Mobile Health Technologies

    Jul 1, 2025, 00:00

  • PCR163 Effectiveness of Co-Creation Physical Literacy Intervention on Weight Control and Physical Fitness Among Obese Children: A PreliminaryInvestigation

    Jul 1, 2025, 00:00

  • EE519 Economic Evaluation of Healthcare Point Solutions Versus Standard Care to Supplement Benefit Plans for Behavioral Health Adults Patients Using Real-World Synthetic Data: A Doubly Robust Causal Analysis

    Jul 1, 2025, 00:00

  • RWD167 Inpatient Hospitalization Trends for COPD in 2018 versus 2021 in United States: A Retrospective Analysis

    Jul 1, 2025, 00:00

  • P24 AI Tools for Literature Reviews: Are Current Guidelines Meeting the Needs of Researchers?

    Jul 1, 2025, 00:00

  • CO95 Comparative Efficacy, Safety, and Tolerability of Xanomeline and Trospium Chloride versus Eight Atypical Antipsychotics for the Acute Treatment of Adults with Schizophrenia - A Network Meta-Analysis

    Jul 1, 2025, 00:00

  • EPH21 Socioeconomic Evaluation of Breast Cancer Attributable to Benzo[a]pyrene (BaP), Nitrogen Dioxide (NO2), and Polychlorinated Biphenyls 153 (PCB-153) Air Pollutants

    Jul 1, 2025, 00:00

  • MSR93 DAGDraw: A Responsive and Modern Directed Acyclic Graph Drawing Tool for Causal Inference and Transportability Analysis

    Jul 1, 2025, 00:00

  • PCR164 Development and Validation of the Symptom Assessment for Bronchiectasis (SABRE) for the FDA Qualification Program: A Novel Patient-Reported Outcome Instrument to Measure Symptoms of Non-Cystic Fibrosis Bronchiectasis

    Jul 1, 2025, 00:00

  • CO62 Comparison of Central Venous Access Device Insertion Proportions, Costs and Removal Time Between Subcutaneous and Intravenous Formulations of Pertuzumab and Trastuzumab in HER2+ Early Breast Cancer Patients

    Jul 1, 2025, 00:00

  • EE416 Molecular Profiling, Treatment (Tx) Patterns, and Healthcare Resource Utilization (HCRU) in United States Patients with Unresectable Locally Advanced/Metastatic Biliary Tract Cancer

    Jul 1, 2025, 00:00

  • CO29 Medication Utilization Post Selective Laser Trabeculoplasty or Minimally Invasive Glaucoma Surgeries in Patients With Open-Angle Glaucoma or Ocular Hypertension: A Systematic Review of Recent Literature

    Jul 1, 2025, 00:00

  • RWD134 Follow Me, If You Can: How Tokenized Linkage Extends Patient Observations in Real-World Databases - the Komodo Research Dataset Example

    Jul 1, 2025, 00:00

  • PT27 Cost-Effectiveness of Delaying Progression of Alzheimer's Disease with Novel Monoclonal Antibodies: A Societal Perspective

    Jul 1, 2025, 00:00

  • CO24 Systematic Literature Reviews (SLRs) Of Clinical Outcomes And Patient-Reported Outcomes Of Recommended Treatments For Patients With Platinum-Resistant Ovarian Cancer (PROC)

    Jul 1, 2025, 00:00

  • EPH51 Trends In Oral JAK Inhibitor And Other Drug Use For Myelofibrosis: A Retrospective Real-World Study

    Jul 1, 2025, 00:00

  • EE504 Characterizing the Burden and Drivers of Healthcare Utilization and Spending for Epilepsy and Seizures in the U.S., 2016-2022

    Jul 1, 2025, 00:00

  • EE437 Out-of-Pocket Health Care Spending Among Medicare Beneficiaries Before and During the COVID-19 Pandemic

    Jul 1, 2025, 00:00

  • PCR193 Treatment Experience and Other Health and Social Characteristics Among Patients With Cancer From a Large US Population-Based Survey

    Jul 1, 2025, 00:00

  • MSR121 An Evaluation of PhlexNeuron, an Internal, Proprietary Artificial Intelligence (AI) Tool for Systematic Literature Review (SLR) Screening

    Jul 1, 2025, 00:00

  • HSD50 Racial/Ethnic Disparities in Veterans' Healthcare Experiences Across VA and Non-VA Settings: An Analysis of the Medical Expenditure Panel Survey (2018-2019)

    Jul 1, 2025, 00:00

  • EPH19 Changes in Respiratory Medication and Antibiotic Use Among Asthma and COPD Individuals During the Pandemic

    Jul 1, 2025, 00:00

  • EE441 Daily Intravenous Ketamine for Treatment-Resistant Depression: a Cost-Effectiveness Analysis Alongside the Clinical Trail

    Jul 1, 2025, 00:00

  • HTA80 Consistency in Reimbursement Decisions for Pediatric Rare Disease Drugsat Canadian HTA Agencies: CDA Versus INESSS

    Jul 1, 2025, 00:00

  • HTA79 Annual Direct Medical Costs with Beta-Thalassemia in the Brazilian Public Healthcare System (SUS)

    Jul 1, 2025, 00:00

  • HPR139 Understanding Japanese Subsidy Initiatives for Rare, Intractable Diseases

    Jul 1, 2025, 00:00

  • HPR25 Artificial Intelligence Software as a Medical Devi Regulatory Approvals and Post-Deployment Evaluation Frameworks in North America and Europe

    Jul 1, 2025, 00:00

  • EE393 Cost-Effectiveness of Umeclidinium/Vilanterol Combination Therapy for Group B COPD Patients

    Jul 1, 2025, 00:00

  • EE227 Medical Costs in Patients with Pulmonary Arterial Hypertension (PAH) on Oral Triple Therapy including Selexipag in the United States (US): A retrospective Claims-Based Study

    Jul 1, 2025, 00:00

  • Psychometric Evaluation of the Proxy-Reported Pediatric Quality of Life Inventory Generic Core Scales Across the Childhood Lifespan in Australian Children and Adolescents With Specified Health Conditions

    Jul 1, 2025, 00:00

  • HPR140 The Importance of Medicare Advantage Plan Design and Impact on Health Equity

    Jul 1, 2025, 00:00

  • EPH7 The Impact of Endoscopic Screening Programs for Gastric Cancer in Japan

    Jul 1, 2025, 00:00

  • MSR29 Reviewing Current Trends Regarding Use of Artificial Intelligence in Generating Real-World Evidence From Patient Medical Charts

    Jul 1, 2025, 00:00

  • PCR53 Redesigning the Care Process to Improve the Experience of Patients with Multiple Sclerosis Throughout the Patient Journey. EMpodera

    Jul 1, 2025, 00:00

  • RWD128 Device Longevity and Survival After Cardiac Resynchronization Therapy Pacemaker (CRT-P) Implantation in the Brazilian Public Health System (SUS): 12-Year Real-World Data Analysis

    Jul 1, 2025, 00:00

  • MT29 Budget Impact Analysis of Continuous Glucose Monitoring with Predictive Alarms for Type 1 Diabetes in Chile (T1D): Perspective of the Explicit Health Guarantees Regime

    Jul 1, 2025, 00:00

  • RWD91 A Retrospective Analysis of Real-World Data: Assessing and Predicting Cardiovascular Risk Associated with Calcium Channel Blockers in Patients with Hypertension

    Jul 1, 2025, 00:00

  • MSR3 Parametric Model Selection: Beyond AIC/BIC in Health Economic Context

    Jul 1, 2025, 00:00

  • EE271 30-Day All-Cause Readmission Outcomes Among Kidney Transplant Recipients with vs. without Autosomal Dominant Polycystic Kidney Disease

    Jul 1, 2025, 00:00

  • EE468 Cost-Effectiveness Analysis of Baricitinib Compared to Standard of Care in Improving Symptoms of Alopecia Areata for the Patients in the U.S. From the Healthcare Payer Perspective

    Jul 1, 2025, 00:00

  • PT1 Developing a Budget Impact R Shiney Application to Assess the Financial Implications of Implementing Organized Cancer Screening Programs in Countries with Limited Resources: Breast Cancer as an Example

    Jul 1, 2025, 00:00

  • Potential Impact of EQ-5D-5L Mapping Function Recently Recommended by the National Institute for Health and Care Excellence on Utility Values and Decision Making

    Jul 1, 2025, 00:00

  • MT40 Prospective, Comparative Study Between Fully-Automated and Semi-Automated Whole Blood Processing Systems in a Colombian Blood Bank Center

    Jul 1, 2025, 00:00

  • EPH183 Gender-Based Gaps In Access to Tricuspid Valve Interventions In England

    Jul 1, 2025, 00:00

  • MSR112 Can Multi-Cancer Early Detection Tests Reduce Cancer Mortality?

    Jul 1, 2025, 00:00

  • HPR117 Racial Disparities in Biomarker Testing Rate, First-Line (1L) Treatment Patterns and Clinical Outcomes Among Real-World Patients in the United States (US) with Advanced or Metastatic Non-Small Cell Lung Cancer (mNSCLC)

    Jul 1, 2025, 00:00

  • CO21 Real-World Evidence on Clinical Outcomes and Safety of Trastuzumab Biosimilar in Colombian Breast Cancer Patients

    Jul 1, 2025, 00:00

  • CO7 Progression From Systemic Lupus Erythematosus to Lupus Nephritis: A Systematic Literature Review

    Jul 1, 2025, 00:00

  • PCR169 Impact of Primary Care Subsidies on Healthcare Utilization: Evidence From Singapore's Merdeka Generation Package

    Jul 1, 2025, 00:00

  • HPR20 Collaborations Between Pharma and Digital Health Startups: Advancing Innovation and Reimbursement in Digital Health Technologies

    Jul 1, 2025, 00:00

  • CO54 Systematic Literature Review and Network Meta-Analysis of Crovalimab Compared With Eculizumab, Ravulizumab and Best Supportive Care in Paroxysmal Nocturnal Hemoglobinuria

    Jul 1, 2025, 00:00

  • EE409 A Systematic Literature Review of Health Economic Models Structures for Chronic Rhinosinusitis with Nasal Polyps

    Jul 1, 2025, 00:00

  • HTA11 A Standardized Framework for the Acceptance of Non-Randomized Evidence From Real-World Data in HTA: Insights From EU Guidelines and National Practices

    Jul 1, 2025, 00:00

  • EE286 Cost-Effectiveness of NALIRIFOX As a First-Line Treatment for Metastatic Pancreatic Cancer in Taiwan

    Jul 1, 2025, 00:00

  • EE483 Efficiency Benefits and Practice Value of Alcon's Digital Cataract Surgery Planning System

    Jul 1, 2025, 00:00

  • PT2 Survival Analysis in Breast Cancer Patients Treated with Targeted Therapies and Conventional Therapies in the US: A Comparative Real World Study

    Jul 1, 2025, 00:00

  • HPR110 Racial Disparities and the Impact of Access Restrictions to Apixaban in Part D

    Jul 1, 2025, 00:00

  • EE258 Burden of Systemic Light-Chain (AL) Amyloidosis by Mayo Stage: Results From an Electronic Health Record (EHR) Linked To Claims Analysis

    Jul 1, 2025, 00:00

  • PT9 Application of ML-NMR to Time-to-Event Outcomes Using Parametric Models and Flexible Parametric (Spline) Models: A Case Study Using A Simulated Dataset

    Jul 1, 2025, 00:00

  • EE292 Evaluating the Value of Over-the-Counter Oseltamivir for Influenza: A Cost-Utility Analysis From U.S. Payer and Societal Perspectives

    Jul 1, 2025, 00:00

  • HTA13 Analysis of Reimbursement Outcomes for Oncology Therapies in Quebec, Canada

    Jul 1, 2025, 00:00

  • EE485 Economic Evaluations of Preventive Interventions for Self-Harm and Suicide: A Systematic Review

    Jul 1, 2025, 00:00

  • HSD29 National Assessment of Prostate and Colon Cancer Screening Using National Health Interview Survey (NHIS)

    Jul 1, 2025, 00:00

  • RWD37 Identifying Treatment Patterns for Essential Thrombocythemia Using Real-world Data

    Jul 1, 2025, 00:00

  • MT16 Economic Impact of Patterned Frequency-Modulated Oral Stimulation in Preterm Infants

    Jul 1, 2025, 00:00

  • HPR65 Early Signals of Inflation Reduction Act Impact on Pharmaceutical Investment and Prioritization Decisions

    Jul 1, 2025, 00:00

  • EPH144 Disease and Economic Burden of Dengue in Colombia, 2018-2022

    Jul 1, 2025, 00:00

  • EE427 Real-World Long-Term Clinical and Economic Outcomes of Preterm Infants with Neonatal Respiratory Distress Syndrome in the United States

    Jul 1, 2025, 00:00

  • HSD72 Virtual Cancer Screening and Support Program: A Model for Improving Cancer Care Continuity Through Screening, Diagnosis, Treatment, and Survivorship

    Jul 1, 2025, 00:00

  • Use of Real-World Data to Support Economic Evaluations of Tumor-Agnostic Therapies: Challenges Remain

    Jul 1, 2025, 00:00

  • EPH36 Global, Regional, and National Burdens of Type 1 and Type 2 Diabetes Mellitus in Adolescents from 1990 to 2021, with Forecasts to 2030: A Systematic Analysis of the Global Burden of Disease Study 2021

    Jul 1, 2025, 00:00

  • HPR9 From Data to Actionable Insight: A Collaborative Monitoring E) Initiative Convened by Canada’s Drug Agency (CDA-AMC) - Piloting Plans for Diabetes and Contraception

    Jul 1, 2025, 00:00

  • HTA23 Broadening the Evidence Base: Incorporating Environmental Considerations Into HTAs

    Jul 1, 2025, 00:00

  • RWD80 Presenteeism in Employees with Chronic Conditions: An Analysis Using Linked Claims and Self-Reported Employee Health Risk Assessment Data

    Jul 1, 2025, 00:00

  • HTA69 A Retrospective Analysis of the Italian Medicines Agency’s Evaluation of Real-World Evidence in Innovativeness Assessments

    Jul 1, 2025, 00:00

  • PCR52 Early Patient-Reported Satisfaction in Patients Initiated on Perfluorohexyloctane for Dry Eye Disease

    Jul 1, 2025, 00:00

  • PCR180 Healthcare Burden Among Patients with Graves Disease: A Targeted Literature Review

    Jul 1, 2025, 00:00

  • HTA25 Assessing Disease Severity: How HTA Bodiea Evaluate Unmet Needs and Influemce Decision-Making

    Jul 1, 2025, 00:00

  • PCR127 A Targeted Literature Review of Patient Perspectives of Placebo Use in Clinical Trials: How Can the Patient Voice Help Drug Developers in Trial Design, Recruitment, and Retention?

    Jul 1, 2025, 00:00

  • RWD127 The Burden of Prader-Willi Syndrome on Patients and the Healthcare System: A cross-Sectional Examination of Emergency Department Visits and Inpatient Stays in US claims

    Jul 1, 2025, 00:00

  • RWD89 Leveraging Consumer-Grade Wearables in Clinical Trials: Insights From Digital Primary Endpoints

    Jul 1, 2025, 00:00

  • MSR141 Reconciling Discrepancies in Results with Different Population-adjusted Indirect Comparison (PAIC) Methods

    Jul 1, 2025, 00:00

  • EE371 A European perspective on Health Resource Utilization (HRU) and Cost outcomes in Patients with Relapsed/Refractory Multiple Myeloma (RRMM): A Systematic Literature Review

    Jul 1, 2025, 00:00

  • EPH5 Disability Progression and Associated Costs in Incident Early-Onset Myasthenia Gravis Patients in France A Longitudinal Cohort Study

    Jul 1, 2025, 00:00

  • PCR84 Health Utility Values of Canadian Patients with Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Metastatic Breast Cancer

    Jul 1, 2025, 00:00

  • EE372 Cost-Effectiveness Analysis of Lenvatinib vs Key Comparators in First-Line Unresectable Hepatocellular Carcinoma in Canada

    Jul 1, 2025, 00:00

  • EPH108 Prenatal Exposure to Antiseizure Medication and Risk of Adverse Obstetrical Outcomes: A Population-Based Study

    Jul 1, 2025, 00:00

  • EE385 Seasonal Variation in Incidence and Outcomes of Hospitalizations with Severe Community-Acquired Bacterial Pneumonia in the U.S., 2018-2022

    Jul 1, 2025, 00:00

  • HTA92 Diffusion and Launch Sequencing of Cell and Gene Therapies across the USA, Europe, Canada and Australia

    Jul 1, 2025, 00:00

  • RWD79 Retrospective Analysis of Cannabis Hyperemesis Syndrome (CHS) Using US Electronic Medical Records: Demographics and Clinical Characteristics

    Jul 1, 2025, 00:00

  • MSR36 Methods for Handling Non-Proportional Hazards in Economic Modeling

    Jul 1, 2025, 00:00

  • HPR84 Trends in Respiratory Pathogen Testing With Individual Pathogen, Small Panel, or Large Panel Polymerase Chain Reaction (PCR) Tests Before and After the Coronavirus Disease 2019 (COVID-19) Public Health Emergency (PHE) Ended

    Jul 1, 2025, 00:00

  • MSR114 Exploring the Impact of Data Availability on Time-Course Model-Based Network Meta-Analysis

    Jul 1, 2025, 00:00

  • HSD69 Patient Characteristics and Treatment Patterns in Extensive-Stage Small Cell Lung Cancer (ES-SCLC)

    Jul 1, 2025, 00:00

  • RWD153 A US Real-World Study of Weight Trajectory and Hypothalamic Damage Among Patients With Acquired Hypothalamic Obesity

    Jul 1, 2025, 00:00

  • PCR179 Patient's Experience of Crohn's Disease: A Conceptual Model Based on Qualitative Interviews

    Jul 1, 2025, 00:00

  • HTA60 Impact of a Digital Musculoskeletal Program on Healthcare Spending Among Participants with Chronic Musculoskeletal Pain and Comorbidities

    Jul 1, 2025, 00:00

  • PCR232 Patient's Experience of Ulcerative Colitis: A Conceptual Model Based on Qualitative Interviews

    Jul 1, 2025, 00:00

  • HPR93 A Targeted Literature Review of Value-Based Agreements (VBAs) for Cell and Gene Therapies in the United States

    Jul 1, 2025, 00:00

  • MSR39 Large Language Model and Contextual Prioritization of Titles and Abstracts for Systematic Review Screening

    Jul 1, 2025, 00:00

  • HPR116 Characterizing Social Determinants of Health in the Population Receiving Pneumococcal Vaccine in a National Pharmacy Chain in the United States

    Jul 1, 2025, 00:00

  • PCR59 Exploring Patient Preferences for Systemic Treatments in Psoriasis: A Review of the Literature

    Jul 1, 2025, 00:00

  • PCR79 Assessing Quality-of-Life Outcomes in Ulcerative Colitis: A Review of Canadian HTA Submissions

    Jul 1, 2025, 00:00

  • HTA1 Pathways to MBS Funding for In-Vitro Diagnostics: Timelines and Success Rates in Australia

    Jul 1, 2025, 00:00

  • HPR45 The Cost of 340B to States

    Jul 1, 2025, 00:00

  • EE394 Health Economic Impact of Introducing an Adult-Focused 21-valent PCV in the Canadian Adult Population

    Jul 1, 2025, 00:00

  • EE355 Healthcare Resource Utilization in the Management of Patients with Relapse/Refractory Mantle Cell Lymphoma in Canada

    Jul 1, 2025, 00:00

  • RWD48 Impact of Circulating Tumor DNA (ctDNA) Burden Among Patients with Head and Neck Dquamous Cell Carcinoma (HNSCC) - A RWE Analysis

    Jul 1, 2025, 00:00

  • PCR60 Exploring Patterns of App-Based Tracking of Real-World Symptom and Treatment Experiences in Patients with Sickle Cell Disease and Cystic Fibrosis

    Jul 1, 2025, 00:00

  • HPR1 Trends in FDA Approvals of Cardiovascular Drugs from 1980 to 2024

    Jul 1, 2025, 00:00

  • HPR158 Is the Biologics Price Competition and Innovation Act Working as Intended?

    Jul 1, 2025, 00:00

  • EE290 Potential Impact of New Strategies of Infant Immunization in the Disease and Economic burden of RSV in Colombia

    Jul 1, 2025, 00:00

  • RWD130 Real-World Adverse Event Profile of Glucagon-Like Peptide-1 Receptor Agonists in Overweight and Obese US Adults

    Jul 1, 2025, 00:00

  • EE472 Cost-effectiveness Analysis of Ferric Carboxymaltose (Renegy®) for the Treatment of Iron Deficiency Anemia During Pregnancy: The Mexican Social Security Institute (IMSS) Perspective

    Jul 1, 2025, 00:00

  • HSD56 Bridging Racial Disparities in Aspirin Therapy for Preeclampsia Prevention Using Virtual Maternity Care

    Jul 1, 2025, 00:00

  • EE356 Cost-Effectiveness of Population-Based Risk Assessment and Hereditary Cancer Genetic Testing in Primary Care

    Jul 1, 2025, 00:00

  • PCR222 Characterizing Improvements in Physical Functioning with PROMIS-PF and In-Trial Exit Interviews: A Mixed-Methods Analysis to Understand the Meaningful Changes Experienced by TGCT Patients on Vimseltinib in the MOTION Trial

    Jul 1, 2025, 00:00

  • EE343 Systematic Literature Review of the Economic Burden of Illness in Advanced or Metastatic Non-Small Cell Lung Cancer in First-Line

    Jul 1, 2025, 00:00

  • EE254 Budget Impact Analysis of Revumenib for the Treatment of Relapsed or Refractory Acute Leukemias With a KMT2A Translocation in the United States

    Jul 1, 2025, 00:00

  • HPR146 Real-World BReast CAncer gene 1 (BRCA1) and BReast CAncer gene 2 (BRCA2) Testing Trends by Race for Patients with Metastatic Prostate Cancer (mPC) from 2015 to 2024 in the Community Oncology Setting in the United States (US)

    Jul 1, 2025, 00:00

  • HPR48 Why It Is Still Important to Ensure the Price is Right: Updates to Access Restrictions for Therapies Treating Duchenne Muscular Dystrophy

    Jul 1, 2025, 00:00

  • MT26 Evaluating the Economic and Environmental Impact of Reprocessed IPC Sleeves for VTE Prophylaxis: a Cost-Consequence Analysis

    Jul 1, 2025, 00:00

  • RWD100 Assessing the Proportion of Days Covered within 180 Days after First Medication Fills Among Bipolar Disorder Patients Using Real-World Data

    Jul 1, 2025, 00:00

  • MSR18 Machine Learning Prediction of 3-Year Mortality in Patients Undergoing Percutaneous Coronary Intervention for Coronary Artery Disease

    Jul 1, 2025, 00:00

  • EE476 Cost-Effectiveness of Pegfilgrastim Versus 5-day Filgrastim in Early Breast Cancer Patients Undergoing Neoadjuvant and Adjuvant Chemotherapy: A Trial-Based Economic Evaluation

    Jul 1, 2025, 00:00

  • HTA82 Use of Real-World Evidence in HTA Submissions and Cost-Effectiveness Evaluations in Asia

    Jul 1, 2025, 00:00

  • EPH172 Exploring Pregnancy-Related Coding Practices in Administrative Claims Data: Insights for Health Outcomes Researchers

    Jul 1, 2025, 00:00

  • EE232 Economic Burden of Chronic Kidney Disease (CKD) in Type 2 Diabetes (T2D), Considering the Costs of Hospitalization Due to Heart Failure (HF) in Colombia

    Jul 1, 2025, 00:00

  • MSR2 Developing a Feature Selection Workflow for Variable-Rich Data: A Case Study Utilizing Claims Data to Build Classifiers for the Prediction of Opioid Use Disorder Among Persons Authorized to Purchase Medical Cannabis

    Jul 1, 2025, 00:00

  • HSD44 Cost of Depression Related Mental Healthcare for Youth During the COVID-19 Pandemic

    Jul 1, 2025, 00:00

  • HPR5 Insight into Approvals, Marketing, and Pricing of New Medicines 2018 to 2022

    Jul 1, 2025, 00:00

  • PCR17 Estimating the Impact of Pill Burden on the Utility of Patients Undergoing Hemodialysis

    Jul 1, 2025, 00:00

  • EPH99 Assessment of Real-World Adverse Events Associated with Ozanimod in Relapsing Remitting Multiple Sclerosis (RRMS)

    Jul 1, 2025, 00:00

  • PCR8 Application of Sentiment Analysis to Aid in Evaluation of Patient Reported Outcome Measures: Analysis of Qualitative Cognitive Debriefing Interviews

    Jul 1, 2025, 00:00

  • EPH122 First-Trimester Antiepileptic Drug Exposure and Adverse Pregnancy Outcomes: Insights from a Cohort Study in the US

    Jul 1, 2025, 00:00

  • HPR89 What Non-Profit Development of Pretomanid Can Teach About Paths to Innovation and Global Access to Treatments for Diseases of Poverty?

    Jul 1, 2025, 00:00

  • RWD39 Examining Patterns in Breast Cancer Patient Characteristics and Treatment Throughout the COVID-19 Pandemic

    Jul 1, 2025, 00:00

  • PCR66 Understanding the Caregiver Experience Through an Exploration of the Literature

    Jul 1, 2025, 00:00

  • HPR138 2025 Review of Gene Therapy Access Landscape

    Jul 1, 2025, 00:00

  • CO50 Analysis of Patient-Reported Outcomes of MCO-010 Mutation Agnostic Optogenetic Therapy for Retinitis Pigmento 12-Month Results from a Phase 2b Randomized, Sham-Controlled, Patient- and Assessor-Masked Clinical Trial (RESTORE)

    Jul 1, 2025, 00:00

  • MT3 Clinical and Economic Benefits of Branched Endovascular Stent Grafting for Intact Thoracoabdominal Aortic Aneurysm Repair: A Real-World Data Analysis

    Jul 1, 2025, 00:00

  • EE494 Cost-Effectiveness Analysis of Axicabtagene Ciloleucel as a Second-Line Treatment for Diffuse Large B-Cell Lymphoma in China

    Jul 1, 2025, 00:00

  • PCR47 Social Listening: A Content Analysis of Social Media Discussions in Prader Willi Syndrome (PWS)

    Jul 1, 2025, 00:00

  • PCR76 Do Existing Caregiver Assessments Measure What's Important to Caregivers?

    Jul 1, 2025, 00:00

  • EE243 Cost of Hypertension Cardiovascular and Renal Complications in Private Healthcare System in Brazil

    Jul 1, 2025, 00:00

  • EPH29 Prevalence of Claims-Reported Pruritus in Patients With Primary Biliary Cholangitis Overall and Among Those Treated With Obeticholic Acid

    Jul 1, 2025, 00:00

  • EE237 Real-World Treatment Patterns, Healthcare Costs and Resource Utilization in First-Line Treatment of Metastatic NSCLC in the US using MarketScan® data

    Jul 1, 2025, 00:00

  • PCR224 Examination of Different Segments of Health Literacy and Health Awareness Among Pregnant Women

    Jul 1, 2025, 00:00

  • EE447 Integrating Dynamic Pricing Into Cost-Effectiveness Models: Implications for US-Based Drug Evaluations

    Jul 1, 2025, 00:00

  • PCR202 An Interim Analysis of the Burden of Influenza Infection on Health-Related Quality of Life and Work Productivity Among Adults in the United States

    Jul 1, 2025, 00:00

  • HSD67 Heterogeneity in Preferences for HIV Self-Testing Among Ugandan Men

    Jul 1, 2025, 00:00

  • EE246 Estimating the Burden of Illness and Healthcare Costs Among Incident Catheter Users: A Comparison of Intermittent and Indwelling Catheter Cohorts Across Spinal Cord Injury, Multiple Sclerosis, Spina Bifida, and Benign Prostatic Hyperp ...

    Jul 1, 2025, 00:00

  • PT18 Prescribing Trends of Disease-Modifying Medications in Texas Medicaid Enrollees with Sickle Cell Disease

    Jul 1, 2025, 00:00

  • PCR154 Information-seekingbehavior of the Hungarian population regarding colorectal cancer: A Digital Epidemiological Study Using Google TrendsTM

    Jul 1, 2025, 00:00

  • PCR73 Discontinuation of Disease-Modifying Therapies in Older Adults with Multiple Sclerosis

    Jul 1, 2025, 00:00

  • RWD16 Leveraging CMS Medicare Data for Oncology RWE: Benefits, Limitations, and Opportunities, and Insights into Enrollment Patterns

    Jul 1, 2025, 00:00

  • PCR81 Physician-Reported Satisfaction with, Challenges in, and Patient Adherence to, Immunosuppressive Treatment among Kidney Transplant Recipients: Results From a Real-World Survey

    Jul 1, 2025, 00:00

  • PT26 Cost-Effectiveness Analysis of Sunvozertinib as a Second-line Treatment for Advanced Non-Small Cell Lung Cancer with EGFR exon20ins Mutation: An Economic Evaluation Based on MAIC

    Jul 1, 2025, 00:00

  • HTA55 Effectiveness of Cell-Free Tumor DNA Tests in Early Lung Cancer Detection

    Jul 1, 2025, 00:00

  • EPH87 Influence of Overweight and Obesity on Disease Progression, Healthcare Utilization and Costs Among People With Prediabetes: A Cohort Study in China

    Jul 1, 2025, 00:00

  • HPR170 Private Insurance May Fail to Protect Against Healthcare Financial Hardship, Evidence from the 2018 and 2019 Medical Expenditure Panel Survey

    Jul 1, 2025, 00:00

  • EE235 Assessing Risdiplam Cost-Effectiveness for Spinal Muscular Atrophy Types I, II, and III in Chile

    Jul 1, 2025, 00:00

  • EE349 Costs of Type 1 Diabetes Acute and Chronic Complications in Brazil Private Healthcare System

    Jul 1, 2025, 00:00

  • EE365 Real-World Healthcare Resource Utilization and Economic Burden Associated With Progressive Pulmonary Fibrosis in Commercially Insured and Medicare Advantage Populations in the United States

    Jul 1, 2025, 00:00

  • EE528 Treatment Patterns, Healthcare Resource Utilization, and Healthcare Costs Among Patients with Metastatic Gastric/Gastroesophageal Junction Cancer in Commercially Insured Patients in the United States

    Jul 1, 2025, 00:00

  • MSR99 Leveraging Social Media Listening and AI: Topic Modeling and RAG Approaches to Analyse Pet Owners' Perspectives on Nonsteroidal Anti-Inflammatory Drugs in Animal Health

    Jul 1, 2025, 00:00

  • EE403 Estimating the Family Spillover Effects of Cardiovascular Diseases: Evidence from the Medical Expenditure Panel Survey

    Jul 1, 2025, 00:00

  • EE360 Short-Term (180-Day) Health Care Costs for Patients With Commercial or Medicare Advantage (MA) Insurance Initiating Glucagon-Like Peptide-1 Receptor Agonist (GLP-1RA) Therapy for Diabetes

    Jul 1, 2025, 00:00

  • HPR134 Hepatitis C Elimination via Subscription-Based Payment Models: A Synthetic Control Study from Washington and Louisiana

    Jul 1, 2025, 00:00

  • MSR68 Development of a Discrete-Time-Updating Algorithm to Predict Cannabis Use Disorder Among Arkansas Medical Marijuana Cardholders

    Jul 1, 2025, 00:00

  • EE320 Impact of Diagnosis Delay on Healthcare Resource Utilization (HCRU) among Patients with Pulmonary Arterial Hypertension (PAH)

    Jul 1, 2025, 00:00

  • CO14 Characteristics of Patients With Bullous Pemphigoid in the US Medicare Population

    Jul 1, 2025, 00:00

  • PCR78 Approaches to Decreasing Emotional Burden during Qualitative Interviews to Improve Data Quality and Participant Engagement

    Jul 1, 2025, 00:00

  • PCR27 Transcultural adaptation of the NutriQoL® questionnaire in American English

    Jul 1, 2025, 00:00

  • EE364 Economic Evaluation of Single-Inhaler Extrafine Beclometasone Dipropionate/formoterol fumarate/glycopyrronium (Trimbow®) in Adult Patients with Uncontrolled Asthma in Mexico

    Jul 1, 2025, 00:00

  • EE500 Cost-Utility Analysis of Dupilumab Versus Omalizumab in the Treatment of Severe Asthma in China

    Jul 1, 2025, 00:00

  • EE297 Budget Analysis of the Implementation of Biosimilars in a Large Private Health Insurance Company in Southern Brazil

    Jul 1, 2025, 00:00

  • HTA18 The Utilization of Qualitative Evidence Synthesis in Brazil’s Public Health System: A Qualitative Analysis

    Jul 1, 2025, 00:00

  • HPR21 Association between Socioeconomic Factors and Guideline-Directed Medical Therapy (GDMT) Utilization Among Medicare Beneficiaries with Heart Failure with Reduced Ejection Fraction (HFrEF)

    Jul 1, 2025, 00:00

  • HSD53 The COM-IC Project: Recommendations for Core Outcome Measurement To Improve (Routine Dementia) Care Quality in Australian Aged Care Settings

    Jul 1, 2025, 00:00

  • EPH119 Chronic Conditions Significantly Increase Risk of Severe RSV Outcomes in Medicaid Beneficiaries Aged 18-59 Years: A Claims Data Analysis

    Jul 1, 2025, 00:00

  • EPH13 Exploring Anemia and the Underdiagnosis of Myelofibrosis: Findings From a Real-World Retrospective Cohort

    Jul 1, 2025, 00:00

  • HSD36 Self-reported CAHPS Quality Measures by Medicare Beneficiary Social Vulnerability Index

    Jul 1, 2025, 00:00

  • EE209 Non-Invasive Tests (NITs) to Risk-Stratify Patients with Noncirrhotic Metabolic-Associated Steatohepatitis (MASH) in a Specialty Setting Eligible for Resmetirom: A Cost-Effectiveness Analysis from a U.S. Payer Perspective

    Jul 1, 2025, 00:00

  • PCR64 Enhancing Early-Phase Trial Outcomes: The Value of Patient-Reported Treatment Tolerability

    Jul 1, 2025, 00:00

  • RWD56 Hospitalization Risk Among Adults With Atopic Dermatitis in Brazil's Public Health System

    Jul 1, 2025, 00:00

  • EE421 Healthcare Cost Comparison Between 1L Ibrutinib and Acalabrutinib in Chronic Lymphocytic Leukemia Patients in the Veterans Affairs Population

    Jul 1, 2025, 00:00

  • HSD24 Patient Characteristics Associated with the Use of Newly Approved Disease-Modifying Therapy (DMT) for Sickle Cell Disease in Texas Medicaid

    Jul 1, 2025, 00:00

  • EPH135 Sex-Stratified Differences in Cardiac Interventions, Complications and Outcomes in the Netherlands Between 2018 and 2023

    Jul 1, 2025, 00:00

  • RWD19 Persistence Patterns of Antidepressants in Mood, Anxiety, and Related Disorders: A Retrospective Cohort Study

    Jul 1, 2025, 00:00

  • MSR53 Development and Validation of an LLM-Based Study Selection Tool for Automating Systematic Literature Reviews: Achieving Time Efficiency and Maintaining Gold Standard Accuracy

    Jul 1, 2025, 00:00

  • EPH84 Epidemiological Insights in Cornelia-de-Lange Syndrome: A Systematic Literature Review

    Jul 1, 2025, 00:00

  • PCR151 Relationship Between Patient Engagement and Weight Management in a Pharmacist-led Clinic within a Managed Care Organization

    Jul 1, 2025, 00:00

  • EE412 The Economic Impact of Indwelling Urinary Catheterization on Total Joint Arthroplasty Procedures and Implications for Urinary Catheter Alternatives: A Systematic Review, Analysis, and Model

    Jul 1, 2025, 00:00

  • EE509 Considerations for Health Economic Modeling in Phenylketonuria (PKU): Insights From a Modified Delphi Panel

    Jul 1, 2025, 00:00

  • SA13 An Assessment of Financial Burden and its Association with Desmoid Tumor Specific Symptoms and Impacts in Adult Desmoid Tumor Patients: Desmoid Tumor Research Foundation Natural History Study

    Jul 1, 2025, 00:00

  • HPR56 Does the 340B Program Encourage and Reward Non-Profit Hospital Consolidation?

    Jul 1, 2025, 00:00

  • PCR133 Does Providing Informal Care to Alzheimer’s Dementia Cause High Caregiver Burden: Insights From Malaysia

    Jul 1, 2025, 00:00

  • MSR124 Impact of NICE Severity Modifiers on Willingness-to-Pay Thresholds

    Jul 1, 2025, 00:00

  • HSD100 Enhanced Outcomes and Reduced Healthcare Utilization with Specialized Home Healthcare Service Providers for Ostomy and Urological Patients: Comparative Research with Pharmacy-Based Care

    Jul 1, 2025, 00:00

  • RWD165 Pioneering the Integration of Health-Equity Variables Into an Administrative Claims Database: A Step Forward in the Journey to Supporting Underserved Populations

    Jul 1, 2025, 00:00

  • EPH131 Estimating US Cancer Prevalence With Community Oncology EHR-Based Datasets via National Benchmarks From SEER and NPCR

    Jul 1, 2025, 00:00

  • EPH129 Evaluation of Availability, Prices, and Affordability of Medicines for Hepatitis B and Hepatitis C Viruses at Community Pharmacies in a Senatorial District in North-Central Nigeria

    Jul 1, 2025, 00:00

  • HPR105 Evaluation of the Cost of Treatment on Endometriosis in the Hungarian Public-Funded Healthcare System

    Jul 1, 2025, 00:00

  • EPH61 Algeria's Healthcare System in 2024: Progress Against Persisting Challenges

    Jul 1, 2025, 00:00

  • SA7 Incorporating Social Drivers of Health Information Into Health Economics and Outcomes Research: Neighborhood-Level Proxies Versus Individual Level Data

    Jul 1, 2025, 00:00

  • EE467 Acute Myocardial Infarction and Associated Healthcare Resource Utilization and Costs Among U.S. Patients With Extreme High Versus Low Lipoprotein (a)

    Jul 1, 2025, 00:00

  • EPH75 Development and Validation of a Machine Learning-based screening Algorithm to Predict High Risk of Hepatitis C Infection

    Jul 1, 2025, 00:00

  • P62 Characteristics of RWE used in Regulatory Decision-Making for Marketing Authorization Applications (MAAs)

    Jul 1, 2025, 00:00

  • PCR118 Real-World Evaluation of Trastuzumab Deruxtecan Administration, Compliance, and Dose Utilization in Chinese Patients With HER2-Positive Advanced Breast Cancer

    Jul 1, 2025, 00:00

  • MT18 Impact of Single-Patient Use Electrocardiogram Monitoring in the Cost of Care and Infection Prevention of CABG Surgery Patients in Canada

    Jul 1, 2025, 00:00

  • EE420 Compare the Return on Investment of Pulsed Field Ablation With Conventional Thermal Ablation for Treatment of Atrial Fibrillation in China

    Jul 1, 2025, 00:00

  • EPH9 A Retrospective Medical Expenditure Panel Survey Database Study Assessing Factors Associated with Health Status Among United States Adults with Asthma

    Jul 1, 2025, 00:00

  • MT7 Latent Class Analysis (LCA) to Identify Medical Device Usage in Real-World Data

    Jul 1, 2025, 00:00

  • EE319 Economic Burden of Opioid-Induced Constipation Among Patients With or Without Cancer in the United States

    Jul 1, 2025, 00:00

  • MSR125 Methodology for Estimating Equal Value Life-Year for Standard Three-State Partitioned Survival Models

    Jul 1, 2025, 00:00

  • EE370 The Costs Associated with Healthcare Resource Use and Work Productivity for Care Partners of Multiple Myeloma Patients in the United States and Europe

    Jul 1, 2025, 00:00

  • MSR45 Explore the Prognostic Factors of Survival Outcomes in Newly Diagnosed Multiple Myeloma Who Are Not Transplant Eligible

    Jul 1, 2025, 00:00

  • EE265 Key Clinical Drivers of the Long-Term Cost-Effectiveness of Semaglutide1mg for the Treatment of People With Type 2 Diabetes and Cronic Kidney Disease Based on the FLOW Clinical Trial

    Jul 1, 2025, 00:00

  • EPH150 Microbiology Testing and Oral Antibiotic Treatment Among CKD Patients With Urinary Tract Infections: Real-World Evidence From a US EMR Network

    Jul 1, 2025, 00:00

  • RWD58 Concomitant Usage of Contra-Indicated Medications in Patients With Atrial Fibrillation: A Comparison of Real-World Data Sources in the United States

    Jul 1, 2025, 00:00

  • HTA33 Streamlined Success or Missed Opportunity: Evaluating the Impact of Simplified Economic Approaches on HTA Recommendations Across CDA-AMC, INESSS and NICE

    Jul 1, 2025, 00:00

  • EPH10 Investigating the Pain Severity and Frequent Exercise Relationship in United States Adults Using the Medical Expenditure Panel Survey

    Jul 1, 2025, 00:00

  • HSD19 Estimating Costs Of Dispensing Services In Community Pharmacies In Taiwan Using A Time-Driven Activity-Based Costing Approach

    Jul 1, 2025, 00:00

  • RWD157 K2GC: Real-world Treatments and Outcomes Amongst Patients With Resectable Gastric (GC) and Gastroesophageal Junction Cancer (GEJC) in the United States (US)

    Jul 1, 2025, 00:00

  • CO87 Association Between Vaginal Progesterone Use and Risk of Preterm Birth Among High-Risk Pregnancies: A Real-World Evidence Study

    Jul 1, 2025, 00:00

  • MSR115 Prediction of Myasthenia Gravis (MG) Crisis Events by a Machine Learning (ML) Algorithm

    Jul 1, 2025, 00:00

  • EE294 Economic Burden of Avoidable Blindness Due to Diabetic Macular Edema in Ecuador

    Jul 1, 2025, 00:00

  • EE481 Budget Impact Analysis of Volanesorsen as a Complement to the Diet in Adult Patients with Familial Chylomicronemia Syndrome (FCS) in Mexico

    Jul 1, 2025, 00:00

  • PCR19 The Unseen Progress: How PROs May Overlook the Value of Slowing Degenerative Decline

    Jul 1, 2025, 00:00

  • PT13 Clinician-Reported Outcomes—A Rare Opportunity for Orphan Labels?

    Jul 1, 2025, 00:00

  • EE410 Real-World Treatment Patterns, Clinical Outcomes, and Healthcare Resource Utilization of Patients with Chronic Lymphocytic Leukemia Treated with Fixed Duration Therapy in a First-Line Setting in Alberta, Canada

    Jul 1, 2025, 00:00

  • PT29 Increased Incidence of Parkinson Disease Associated with Antiseizure Medication Use

    Jul 1, 2025, 00:00

  • HTA83 Enhancing Health Technology Assessment With Data Transportability Analyses: Addressing Bias and Generalizability Challenges In Non-Local Real-World Evidence

    Jul 1, 2025, 00:00

  • EE517 Willingness to Pay for a Quality Adjusted Life Year Across Different Time Horizons: Direct Elicitation in Quebec

    Jul 1, 2025, 00:00

  • PCR9 Empowering Patients in Observational Research: Leveraging Data Insights for Sustained Engagement and Innovation

    Jul 1, 2025, 00:00

  • EPH152 Trends in Cardiovascular and Cancer Mortality Among Texas Residents with Cancer between 2010 and 2019

    Jul 1, 2025, 00:00

  • HPR47 Impacts of the Inflation Reduction Act on 2025 Formulary Coverage in Medicare Part D Plans

    Jul 1, 2025, 00:00

  • CO18 Assessing the Comorbidity Burden of Ehlers-Danlos Syndromes (EDS): An Analysis Using US Real-World Data

    Jul 1, 2025, 00:00

  • PCR128 Validation of a Questionnaire to Evaluate Simplicity of Diabetes Treatment (SIM-Q)

    Jul 1, 2025, 00:00

  • PCR216 Predicting Future Type 1 Diabetes Onset Risk; A Machine Learning Approach

    Jul 1, 2025, 00:00

  • EE516 Cost-Effectiveness Analysis of Adjuvant Pembrolizumab Versus Standard-of-Care (SOC) Immunotherapies (High-Dose interferon Alfa 2-b or Ipilimumab) in High-Risk Resected Melanoma in United States (US)

    Jul 1, 2025, 00:00

  • EPH89 What Are the Characteristics Associated With Frequent Physical Exercise Among Adults With Arthritis? Results of a National Survey in the United States

    Jul 1, 2025, 00:00

  • HPR64 ICER Thresholds in Cost-Utility Analysis: Assessing Conceptual Relevance and Practical Adequacy for Drug Reimbursement Decision-Making in The US

    Jul 1, 2025, 00:00

  • CO22 Real-World Effectiveness of Alcohol Use Disorder Treatment on Healthcare Utilization and Expenditure Among U.S. Adult Cancer Survivors: A Propensity-Score Matched Cohort Study

    Jul 1, 2025, 00:00

  • PCR210 Association Between Caregiver Quality of Life and the Care Provided to Adults With Severe Visual Impairments: A Systematic Literature Review

    Jul 1, 2025, 00:00

  • EPH136 Demographic Characteristics, Utilization Trends, and Access to GLP-1 Agonists Among Adults in a Nationally Representative Pharmacy Database

    Jul 1, 2025, 00:00

  • PCR31 The Impact of Mucopolysaccharidosis Type III (MPS III) on Family and Finances: A Caregiver Perspective

    Jul 1, 2025, 00:00

  • HPR36 Estimated Impact of the Inflation Reduction Act on Out-of-Pocket Spend Among Medicare Part D Beneficiaries with Cancer

    Jul 1, 2025, 00:00

  • RWD49 Development and Application of a Novel Framework for Clinician Stakeholder Engagement in Real-world Data (RWD) Studies

    Jul 1, 2025, 00:00

  • EE202 Economic Evaluations of Imaging Guidance for Percutaneous Coronary Interventions: A Scoping Review

    Jul 1, 2025, 00:00

  • CO34 Real-World Cancer Recurrence and Overall Survival Outcomes in Muscle-Invasive Bladder Cancer (MIBC) Patients Treated With Radical Cystectomy (RC): A Retrospective Surveillance, Epidemiology, and End Results-Medicare Study

    Jul 1, 2025, 00:00

  • CO45 Systematic Review of Secondary Primary Malignancies (SPMs) in Patients Treated with Chimeric Antigen Receptor T-cell (CAR-T) Therapies

    Jul 1, 2025, 00:00

  • PCR99 Mapping between the HUI2/HUI3 and the PROPr in the United States

    Jul 1, 2025, 00:00

  • PCR129 Utility Values From Individuals With Knee Osteoarthritis in the UK

    Jul 1, 2025, 00:00

  • HPR27 US Food and Drug Administration Approvals, Regulatory Pathways, and Review Time of New Drugs and Biologics, 1980–2024

    Jul 1, 2025, 00:00

  • PT10 Patient-Reported Outcome Endpoint Emulation in Heart Failure External Control Arm Study (EMULATE-HF PRO-ECA Study)

    Jul 1, 2025, 00:00

  • EE338 Avoidable Costs by the Inclusion Ff Finerenone in Terms of Hospitalization Due to Heart Failure (HF) and the Progression of Chronic Kidney Disease (CKD) in Type 2 Diabetes (T2D) in Colombia

    Jul 1, 2025, 00:00

  • OP5 Analysis of the Human Development Index by Innovation In Health, Through the Incorporation of New Technologies In Oncology: Preliminary Data in LMIC/LATAM/Brazil

    Jul 1, 2025, 00:00

  • CO56 Comparison of Selective Serotonin Reuptake Inhibitors and USA Food and Drug Administration-Approved Serotonin-Norepinephrine Reuptake Inhibitors Treatments for Fibromyalgia: A Systematic Review and Network Meta-Analysis

    Jul 1, 2025, 00:00

  • EE405 Trial-Based Economic Evaluation of 'Partner in Balance,' a Blended Self-management Program for Early-Stage Dementia Caregivers in the Netherlands: The Health-Economic Analysis Plan and Baseline Results

    Jul 1, 2025, 00:00

  • HTA26 The Impact of CDA-AMC Sequential Analysis on Decision-Making in Oncology

    Jul 1, 2025, 00:00

  • EPH23 Epidemiology and Disease Burden of Atherosclerotic Cardiovascular Disease, Chronic Kidney Disease, and Systemic Inflammation in Northern China: A Retrospective Study of Tianjin Regional Electronic Health Records

    Jul 1, 2025, 00:00

  • EE479 Modeling in R: Tutorial for Beginner Using a Cost-Effectiveness Analysis Made With Microsoft Excel

    Jul 1, 2025, 00:00

  • EE392 State of Evidence on Cost-Effectiveness Analysis of Health Technologies in Colombia: A Systematic Literature Review

    Jul 1, 2025, 00:00

  • HTA12 Navigating Uncertainty in Overall Survival Data: Insights from Positive Canadian HTAs on Lung Cancer Therapies

    Jul 1, 2025, 00:00

  • HPR43 Unlocking the Potential of OBRSAs in the US: Insights on Challenges, Policy Changes, and Pathways Forward

    Jul 1, 2025, 00:00

  • EE431 Healthcare Costs and Resource Use in Patients With Sjögren's Syndrome (SS): A Systematic Literature Review of Real-World Evidence (RWE) Studies

    Jul 1, 2025, 00:00

  • CO91 Real-World Events Often Associated with Relapse (EOAR) Rates Among Patients with Multiple Sclerosis on Natalizumab Using Claims Data from the PearlDiver Mariner Database

    Jul 1, 2025, 00:00

  • PCR21 Health-Related Quality of Life and Associated Factors Among Patients With Chronic Diseases in Hainan Province, China

    Jul 1, 2025, 00:00

  • PCR156 Frequency and Severity of COVID-19 Acute Symptoms Among Symptomatic US Adults Testing Positive for SARS-CoV-2: Early 2024-2025 Respiratory Season Results of a Nationwide Study

    Jul 1, 2025, 00:00

  • HPR107 Trends in Breast Cancer Drugs Approved by the US Food and Drug Administration, 1980-2024

    Jul 1, 2025, 00:00

  • RWD22 Development and Validation of a Claims-Based Approach to Identify Patients with Metastatic HR+ HER2- Breast Cancer

    Jul 1, 2025, 00:00

  • HPR42 The Emerging Potential of International Reference Pricing (IRP) in the US: An Analysis of Trends, Challenges, Opportunities and learnings from Europe

    Jul 1, 2025, 00:00

  • HSD20 An Analysis of Hospitalization Metrics After Intravenous (IV) Ferric Derisomaltose (FDI) versus Usual Care (UC) in Patients with Iron Deficiency Anemia (IDA) and Heart Failure (HF) Based on IRONMAN

    Jul 1, 2025, 00:00

  • HTA90 Economic Impact of Implementing a Clinical Protocol and Therapeutic Guidelines for Cow's Milk Protein Allergy in Two States of Brazil

    Jul 1, 2025, 00:00

  • PCR166 Tremor Symptoms and Associated Activities of Daily Living Impacts in Essential Tremor: A Qualitative Concept Elicitation and Mapping Study

    Jul 1, 2025, 00:00

  • HSD49 Diagnosis and Treatment Journey of Patients With Atrial Fibrillation Prior to Stroke Occurrence

    Jul 1, 2025, 00:00

  • MSR88 Key Considerations in the Use of Large Language Models for Data Extraction in Health Economics and Outcomes Research

    Jul 1, 2025, 00:00

  • HPR57 Comparing the Social and Private Value Created by Pembrolizumab 2014-2022

    Jul 1, 2025, 00:00

  • EPH52 Protocol for a Real-World Retrospective Study on Chronic Obstructive Pulmonary Disease Outcomes Among Individuals Switching to Heated Tobacco Products Compared to Continued and Former Cigarette Smokers in Japan

    Jul 1, 2025, 00:00

  • EE489 Costs of Initiated Potentially Inappropriate Medication in 2021-2022 in Quebec, Canada

    Jul 1, 2025, 00:00

  • RWD169 Real-World Utilization and Predictors of Neurohormonal Inhibitors Use in Young and Middle-Aged Breast Cancer Patients, Initiating Anthracycline-Based Treatments

    Jul 1, 2025, 00:00

  • MT15 RtCGM Use is Associated with Improved Glycemic Control Compared to isCGM in Commercially Insured People with Type 2 Diabetes on Semaglutide and Insulin

    Jul 1, 2025, 00:00

  • EPH124 EHR Trends in First-Time ADHD Diagnoses and Amphetamine Prescriptions Across Age Groups (2021-2024)

    Jul 1, 2025, 00:00

  • MSR140 Adapting PRISMA For System Dynamics Models In Healthcare: A Case Study Of Transcatheter Aortic Valve Implantation In Canada

    Jul 1, 2025, 00:00

  • MSR82 Effectiveness of Activity Criteria in Stabilizing Patient Cohorts in Open Claims Data for Healthcare Outcomes Research

    Jul 1, 2025, 00:00

  • HPR171 Comparison of Therapeutic Efficacy by Disease for Outpatients Using Herbal Decoctions Based on the Using the Usage and Consumption of Korean Medicine Report in 2020

    Jul 1, 2025, 00:00

  • MSR10 Real-time Predictions of Maternity Episode Expenses Using Machine Learning

    Jul 1, 2025, 00:00

  • EPH178 Estimates of the Public Health Impact of Norovirus Vaccination for Older Adults in the United States

    Jul 1, 2025, 00:00

  • CO23 Real-World Effectiveness of Tirzepatide vs. Semaglutide on HbA1c and Weight in GLP-1 RA Naïve Patients with T2D

    Jul 1, 2025, 00:00

  • EE346 The Clinical Value and Cost-Effectiveness of DefenCath for Reducing Catheter-Related Bloodstream Infections in Adult Patients Receiving Hemodialysis Through a Central Venous Catheter

    Jul 1, 2025, 00:00

  • MSR79 The Impact of Prior Choice for Between-Study Heterogeneity in Network Meta-Analysis on Model Conclusions

    Jul 1, 2025, 00:00

  • EE210 Nirsevimab for RSV Prevention in Hong Kong Infants: A Cost-Effectiveness Analysis

    Jul 1, 2025, 00:00

  • Health Impact and Cost-Effectiveness of Testing and Treatment of Mycobacterium Tuberculosis Infection Among Asian and Hispanic Persons With Diagnosed Diabetes in the United States

    Jul 1, 2025, 00:00

  • PCR237 Evaluating Thresholds for Minimal Clinically Important Difference (MCID) in Patient-Reported Outcome Measures (PROMs) in Locally Advanced or Metastatic Urothelial Cancer (la/mUC): a Systematic Literature Review (SLR)

    Jul 1, 2025, 00:00

  • HPR144 Factors Delaying the Public Listing of New Drugs in Canada

    Jul 1, 2025, 00:00

  • EPH187 Association of Sleep Disturbances With Mild Cognitive Impairment Among Adults in the US

    Jul 1, 2025, 00:00

  • RWD150 The HER2-TRENDS StudyHR Positive - HER2 Negative Metastatic Breast Cancer (mBC) Treatment Patterns and Clinical Outcomes in Canada

    Jul 1, 2025, 00:00

  • Reviewer Acknowledgment

    Jul 1, 2025, 00:00

  • CO84 Hydroxyurea Use and Clinical Outcomes Among Adults with Severe Sickle Cell Disease: A retrospective Cohort Study using Electronic Health Record Data

    Jul 1, 2025, 00:00

  • EE510 An Economic Model to Evaluate the Impact of Formulary Tier Increases for Apixaban on the Incidence and Cost of Clinical Events in Patients with Non-Valvular Atrial Fibrillation in the United States

    Jul 1, 2025, 00:00

  • PCR147 Comparison of Rare Disease Patient and Caregiver Perceptions Regarding Access to Disease Information and Interactions with their Healthcare Providers: Results from an International Survey

    Jul 1, 2025, 00:00

  • P32 Oncology Trial Emulation Using Real-World Electronic Health Record Data: Results of the Coalition to Advance Real-World Evidence Through Randomized Controlled Trial Emulation (CARE) Initiative

    Jul 1, 2025, 00:00

  • HTA71 The Prevalence of Fractional-Polynomial Network Meta-analyses (fpNMAs) in Supporting Reimbursement Recommendations by Canada's Drug Agency (CDA-AMC)

    Jul 1, 2025, 00:00

  • EE327 Belantamab Mafodotin, Pomalidomide, and Dexamethasone (BPd) in Relapsed/Refractory Multiple Myeloma (RRMM): Quality-Adjusted Life-Year (QALY) Results From a Cost-Effectiveness Model

    Jul 1, 2025, 00:00

  • HSD54 Receipt of Guideline Concordant Treatment Among Older Adults Newly Diagnosed With Stage III - IV Melanoma Using SEER-Medicare Linked Data

    Jul 1, 2025, 00:00

  • RWD151 Real-World Evidence on the Use of Secondary Prevention for People With ASCVD or CKD: A Systematic Literature Review

    Jul 1, 2025, 00:00

  • PT33 Reliability and Validity of EuroQol-5 Dimensions-5 Levels in Patients with Hematologic Malignancies: A Cross-Sectional Study

    Jul 1, 2025, 00:00

  • PCR219 Quality-of-Life, Symptom Burden, and Tolerability in Frail Patients without Caregivers in Real-world Oncology Practice

    Jul 1, 2025, 00:00

  • EE341 Economic Burden of Prader-Willi Syndrome Among Pediatric Patients in the United States

    Jul 1, 2025, 00:00

  • PCR93 Beyond Clinical Data: Assessing Usage Patterns of Real-World Home-Reported Outcomes To Capture the Full Burden of Atopic Dermatitis Symptoms and Flares

    Jul 1, 2025, 00:00

  • HTA10 Patient Voice in Rare Disease Health Technology Assessments: Recent Trends in the Use of Qualitative Research in Reimbursement Submissions to Canada's Drug Agency

    Jul 1, 2025, 00:00

  • RWD82 Healthcare Resource Utilization 12 Months Following Initiation of Olanzapine/Samidorphan: Real-World Assessment of Patients With Bipolar I Disorder

    Jul 1, 2025, 00:00

  • EPH85 Real-World Temporal and Indication-Specific Variation in Drivers of GLP-1 RA Discontinuation

    Jul 1, 2025, 00:00

  • P27 Use of Metamodels in Health Economics to Bypass Complexity and Democratize Modeling

    Jul 1, 2025, 00:00

  • HSD59 Disparities in Tardive Dyskinesia Diagnosis and Treatment Among the US Medicare Population

    Jul 1, 2025, 00:00

  • PCR241 Beyond Overall Survival: Advancing the Understanding and Use of Surrogate Endpoints in Oncology

    Jul 1, 2025, 00:00

  • MSR33 Automated Extraction of Kaplan-Meier Survival Curves Using Generative Artificial Intelligence and Computer Vision

    Jul 1, 2025, 00:00

  • EE324 Cost Analysis of Surgical Treatment for Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) Refractory to Clinical Therapy in Brazil

    Jul 1, 2025, 00:00

  • EPH173 Baseline Risk of Hospitalization and Mortality in High-Risk Subgroups of a Nirmatrelvir/Ritonavir Treatment-Eligible Population With Mild-to-Moderate COVID-19 in the United States: A Systematic Literature Review

    Jul 1, 2025, 00:00

  • PT19 Timing of Health Technology Assessment in the United States: An Evaluation of ICER Reviews Over Seven Years

    Jul 1, 2025, 00:00

  • CO70 Cannabinoids for Symptom Management in Children and Adolescents with Autism Spectrum Disorder: A systematic Review and Meta-Analysis

    Jul 1, 2025, 00:00

  • EE443 Costs Avoided by the Inclusion of Finerenone Based on Hospitalization and Death Due to Cardiovascular Events and the Progression of Chronic Kidney Disease (CKD) in Type 2 Diabetes (T2D) in Colombia

    Jul 1, 2025, 00:00

  • MSR96 GenAI for Critical Appraisal of Evidence for Systematic Literature Reviews (SLRs): A Face-Off between GenAI and Human Reviewers

    Jul 1, 2025, 00:00

  • EE299 Cost Per PFS-Based Responder for TKI-Naive Patients Receiving Repotrectinib or Entrectinib in ROS1 Fusion Positive Non-Small Cell Lung Cancer (NSCLC) in the United States (US)

    Jul 1, 2025, 00:00

  • PCR230 Patient-Reported Outcomes From a Phase 3 Study of Givinostat in Patients With Duchenne Muscular Dystrophy

    Jul 1, 2025, 00:00

  • EPH101 National Respiratory Surge Forecasting With Combined Pharmacy and Public Health Data

    Jul 1, 2025, 00:00

  • HPR145 Medicare Spending on Orphan Drugs With Single and Multiple Rare Disease Indications

    Jul 1, 2025, 00:00

  • PCR253 Psychometric Evaluation of the ASCOT-SCT4, a Preference-Based Quality of Life Instrument for Social Care Service Users in Hong Kong: An Application of Item Response Theory

    Jul 1, 2025, 00:00

  • MSR94 To Bootstrap, or Not to Bootstrap Before Multiple Imputation: That Is the Question

    Jul 1, 2025, 00:00

  • EE376 Treatment Patterns and Healthcare Resource Utilization of Patients Early in Schizophrenia Illness Initiating Aripiprazole Lauroxil Versus Oral Aripiprazole: A Retrospective Claims-Based Study

    Jul 1, 2025, 00:00

  • EPH130 Racial/Ethnic Disparities in Pneumococcal Vaccination Rates Among the Elderly: Trends and Associated Factors in the U.S., 2018-2023

    Jul 1, 2025, 00:00

  • CO1 Assessment of Disease Progression and Healthcare Resource Utilization Associated with Duchenne Muscular Dystrophy: A Retrospective Observational Study Using the Optum Market Clarity Database

    Jul 1, 2025, 00:00

  • PCR198 Evaluating the Influence of User-Complexity on Individual Preferences for Upper Limb Prosthetic Selection: Measurement Tool Development for a Discrete Choice Experiment

    Jul 1, 2025, 00:00

  • EE337 Economic Burden of Rheumatoid Arthritis in Low- and Middle-Income Countries: Systematic Review

    Jul 1, 2025, 00:00

  • CO63 Racial Disparities in the Burden of Illness Among Adults with Prostate Cancer in the United States

    Jul 1, 2025, 00:00

  • EPH48 Variables Statistically Associated With Mental Health Among United States Adults With Asthma in the Medical Expenditure Panel Survey

    Jul 1, 2025, 00:00

  • EE241 Cost-Savings of Primary Healthcare Nurse Practitioners' Planned Interventions for Reducing Transfers of Patients from Home Care to Emergency Departments in Quebec, Canada

    Jul 1, 2025, 00:00

  • EPH111 Epidemiology of Polymyalgia Rheumatica: A Targeted Literature Review

    Jul 1, 2025, 00:00

  • HPR37 Navigating the IRA: Impact of Medicare Part B Rebates on Drug Pricing and Manufacturer Strategies

    Jul 1, 2025, 00:00

  • RWD15 Characteristics of Patients With Minimal Residual Disease (MRD) Testing for Solid Tumors in a United States Population With Commercial or Medicare Advantage (MA) Insurance

    Jul 1, 2025, 00:00

  • RWD148 Epidemiological Estimates of Interstitial Lung Diseases in Mexico: A Real-World Data Analysis of 2,591,278 Hospital Discharges From the Ministry of Health

    Jul 1, 2025, 00:00

  • MSR97 An “R-Shiny” Interface Designed As a One-Stop Solution for All Kinds of Indirect Treatment Comparisons According to NICE Technical Support Documents 2, 3, and 18

    Jul 1, 2025, 00:00

  • EE222 Budget Impact Model to Evaluate the Inclusion of a Pre-Filled Syringe Compared to Vial Application of Denosumab in Patients with Four Cancer Types in Mexico

    Jul 1, 2025, 00:00

  • EE480 Surgical Stripping and Ligation Compared to Cyanoacrylate Vein Closure in the Mexican Public Healthcare Setting: Direct Costs and Incapacity Pay

    Jul 1, 2025, 00:00

  • RWD10 Characterizing Cardiovascular Disease Patients in US Community Hospitals Using InsightsDB

    Jul 1, 2025, 00:00

  • HPR83 China's National Reimbursement Drug List (NRDL) Negotiation: Value Considerations and Key Factors Influencing Payment Standards

    Jul 1, 2025, 00:00

  • HPR33 Consumption and Expenditure of WHO Essential Medicines for Cancer: Drug Utilization Analysis of 40 Countries and Regions from 2012 to 2022

    Jul 1, 2025, 00:00

  • RWD123 Pharmacovigilance Studies Using a Representative Sample From the French National Health Insurance Database (ESND): A Targeted Literature Review

    Jul 1, 2025, 00:00

  • MSR38 GenAI Goes to ISPOR: Exploratory, Descriptive Analysis of Generative AI Performance for Summarizing and Synthesizing ISPOR Research Abstracts as Sources

    Jul 1, 2025, 00:00

  • CO77 External Control Arm With Real World Data to Assess the Effect of Semaglutide on Chronic Kidney Disease Risk Among Patients With Type 2 Diabetes

    Jul 1, 2025, 00:00

  • PT37 Operationalizing an Outcomes-Based MarketAccess Agreement Using Real-World Data From the Canadian Neuromuscular Disease Registry

    Jul 1, 2025, 00:00

  • RWD102 Impact of Adverse Event Definitions on Real-World Detection of Oncology Immune-Related Adverse Events

    Jul 1, 2025, 00:00

  • RWD14 Estimating Healthcare Resource Utilization and Direct Costs of Chronic Myeloid Leukemia in the Brazilian Public Health System

    Jul 1, 2025, 00:00

  • HPR112 Impact of New Cervical Cancer Screening Program Using Human Papillomavirus (HPV) Deoxyribonucleic Acid (DNA) Testing on Urban-Rural Disparities in Thailand: A Post-Hoc Distributional Cost-Effectiveness Analysis

    Jul 1, 2025, 00:00
  • 1
  • 2
  • 3 (current)
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • »